for the treatment of overactive bladder (OAB).This is the first time that CTAF has addressed this topic.

With the recent approval of tolterodine and oxybutynin XL, we believe that the list of agents previously considered first- and second-line medications for the overactive bladder needs to be revised.

Oct. 9, 2024 — A new study has found some cancers to be slightly more frequent in people with multiple sclerosis (MS) than in people without MS. Types of cancers found to have a small increased ...

After rejecting ImmunityBio’s Anktiva last year, the FDA has cleared the drug as a treatment for bladder cancer, making it the company’s first commercial-stage product. Anktiva (nogapendekin ...

Promoting the appropriate use of these drugs helps maintain Canada's high public health standards. Among its initiatives related to antimicrobial resistant infections, Health Canada has created a ...

According to the National Institute of Mental Health (NIMH), more than one in five adults (about 20%) in the United States has a mental health condition. Treatments for mental health conditions are ...

And how much does it really cost to bring a drug to market? Increasingly, though, these debates are happening when everyone knows that the list price is not the ‘real’ price to be paid ...

Boston Scientific Corporation today announced the close of its acquisition of Axonics, Inc. , a medical technology company focused on the development and commercialization of differentiated devices to ...

Symptoms can range from acute (short-term) mania to depression and depressive episodes. Luckily, multiple treatments exist that can help you manage the condition. Medications such as mood stabilizers, ...

After hours: November 15 at 7:55 PM EST Loading Chart for DRUG ...

According to a release, the new deal will see a reduction in franchise payables with Riot Games eliminating $2m (~£1.57m) that was due in 2025. OverActive Media noted that the new agreement will give ...